Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
triamcinolone acetonide + mepivacaine hydrochloride
- Development stage
- Unknown
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Administration
- Intraarticular
01
Overview
A combination medication consisting of triamcinolone acetonide (a synthetic glucocorticoid corticosteroid) and mepivacaine hydrochloride (a local anesthetic). This combination is administered via intra-articular injection to provide both immediate pain relief and longer-term anti-inflammatory effects for various joint conditions. Mepivacaine provides rapid analgesia (within 45 minutes) while triamcinolone reduces inflammation, edema, and synovial fluid protein concentration. The combination is particularly effective for acute synovitis, gout attacks, and other inflammatory joint conditions.
- Brand names
- EpirelefanMepecaine 3%
- Other names
- triamcinolone acetonide + mepivacaine hydrochloride
02
Targets
GR (Glucocorticoid receptor)NaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on triamcinolone acetonide + mepivacaine hydrochloride.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on triamcinolone acetonide + mepivacaine hydrochloride.